Pinealon

Mechanism

Oligopeptide regulatory effects on brain tissue.

Reported effects

What sources associate with this compound. Reported categories, not outcomes we have graded — each would need its own citation and rung.

• Cognitive support
• Neuroprotection
• Stress resilience

Reconstitution

mass ÷ diluent = concentration; dose ÷ concentration = volume; volume × the syringe factor = units on the barrel (100 for U-100, 40 for U-40). Run your own numbers.

Literature on file 2

• animal in vivo
  Pinealon Increases Cell Viability by Suppression of Free Radical Levels and Activating Proliferative Processes (Rejuvenation Research 2011, cited 12x) graded on: an animal model — read from the indexed abstract — “rats”
• animal in vivo
  Pinealon corrects hyperhomocysteinemia-induced disturbances of the diurnal dynamics of hypothalamic norepinephrine content in female rats (Neurochemical Journal 2014, cited 3x) graded on: an animal model — “rats”

What is circulated not evidence 4

Claims passed around in community guides and vendor copy, recorded because they circulate — not because they are true. Each is shown with the page it was read from and what this record actually holds. Checked 2026-08-24.

• unverified community data dose ubiquitous contradicts the record

  5 to 10 mg subcutaneously per day in short courses of ten to twenty days is the protocol community sources cluster on, one to three courses a year.

  5-10 mg subcutaneously per day in short 10-20 day courses

  On the record The record holds 1-2 mg per administration daily on a 2-3 week cycle, and marks it unverified. The circulated dose is five times the top of that range, though the course length matches. Neither figure has a study named against it: the record's only basis is an animal model.

  Source 1 · Source 2 · Source 3

• unverified community data sourcing common agrees with the record

  Guides state plainly that no human clinical trial has established a dose, schedule or safety profile for pinealon, and that most published data comes from a single research programme.

  No human clinical trial has established a dose, schedule, or safety profile

  On the record The record grades pinealon an animal study on an animal model, and holds no half-life, so it is consistent with the absence of human data. That the published work comes from a single research group is not on file.

  Source 1

• unverified community data side effect common nothing on file either way

  Mild injection-site redness or irritation is the most commonly mentioned issue in community reports.

  Injection-site reactions — the most commonly mentioned issue in community reports (mild redness or irritation)

  On the record No side effect is on file for pinealon.

  Source 1

• unverified community data dose ubiquitous nothing on file either way

  Subcutaneous injection is the route assumed by every dosing chart.

  Subcutaneous injection

  On the record The record lists four routes — subcutaneous, intramuscular, intranasal and oral — with no dose, bioavailability or half-life distinguishing them. It offers three routes the community never discusses, and cannot say what a dose means on any of them.

  Source 1 · Source 2

Identity

PubChem CID 10273502 computed 3D conformer

Skeletal formulathe canonical depiction

Drawn by PubChem from CID 10273502, the identifier on this record.

Molecular weight

418.40

Molecular formula

C15H26N6O8

CAS number

175175-23-2

PubChem CID

10273502

InChI key

QPRZKNOOOBWXSU-CIUDSAMLSA-N

Sequence

EDR

SMILES

C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)CN=C(N)N

InChI

InChI=1S/C15H26N6O8/c16-7(3-4-10(22)23)12(26)21-9(6-11(24)25)13(27)20-8(14(28)29)2-1-5-19-15(17)18/h7-9H,1-6,16H2,(H,20,27)(H,21,26)(H,22,23)(H,24,25)(H,28,29)(H4,17,18,19)/t7-,8-,9-/m0/s1

Classified as

Subcutaneousroute

This is the route the reconstitution arithmetic assumes. Mass divided by diluent volume gives concentration, dose divided by concentration gives volume, and volume in mL multiplied by 100 gives units on a U-100 barrel: 5 mg in 2 mL is 2.5 mg/mL, and 0.25 mg comes out at 0.1 mL, which is 10 units.

Intranasalroute

A nasal device delivers a fixed volume per spray, so concentration rather than syringe volume sets the amount per spray, and a mass figure on a record is not usable until you know how many actuations it was divided across.

Oralroute

Route sets what a milligram means. An oral figure and an injected figure for the same compound are not comparable amounts, and treating one as the other is one of the commonest ways a record gets misread.

Also called

• Pinealon

Listed prices 102

What 82 shops we track listed for Pinealon, read from their own public catalogues on 2026-09-14. We take no commission on these and they are not ranked by any payment — how vendors are scored.

Share this record